2097129-93-4
2097129-93-4
Chemical Structure
Larotinib mesylate hydrate
- CAS. Nr.: 2097129-93-4
- Formula:C26H36ClFN4O11S2
- Molecular Weight:699.17
IUPAC Name: N-(3-chloro-4-fluorophenyl)-6-(3-((4aR,7aS)-hexahydro-6H-[1,4]dioxino[2,3-c]pyrrol-6-yl)propoxy)-7-methoxyquinazolin-4-amine dimethanesulfonate hydrate
InChIKey: SOZDTNWXBLYRLP-GQOINVLUSA-N
SMILES: COC(C(OCCCN1C[C@]2([H])[C@](OCCO2)([H])C1)=C3)=CC4=C3C(NC5=CC(Cl)=C(C=C5)F)=NC=N4.CS(=O)(O)=O.CS(=O)(O)=O.O
Biological Activity: Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Larotinib mesylate hydrate | 98.66% | Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
